Home » Applications » Oncology

Oncology imaging for deeper biological insight

See oncological biology more clearly, so you can understand tumor systems, quantify molecular activity within the tumor, and evaluate therapeutic response with confidence.

MILabs supports preclinical oncology research by helping teams visualize and measure key biological processes within tumors, including tracer uptake, biodistribution, microenvironment dynamics, and response over time. By combining molecular and anatomical imaging in aligned workflows, researchers generate clearer insight while reducing complexity and variability across studies.

Discover all other applications.

MILabs equipment for oncology applications

Interpret tumor biology with greater confidence through aligned molecular and anatomical insight in a single workflow.

MILabs imaging systems provide oncology researchers with high-resolution, quantitative data across a wide range of study designs. Flexible configurations allow teams to correlate molecular signals with structural context, compare tracers directly, and generate reproducible datasets that support translational and advanced research.

MILabs imaging systems provide oncology researchers with high-resolution, quantitative data across a wide range of study designs

Benefits of MILabs systems for oncology research

Ultra-high-resolution imaging of tumor biology

Resolve small structures and subtle biological signals, so you can study tumor heterogeneity with greater precision.

MILabs systems support ultra-high-resolution molecular imaging that enables accurate quantification of tracer behavior within tumors and surrounding tissue. This level of detail supports deeper investigation of biological variability, uptake patterns, and treatment response.

Integrated molecular and anatomical insight

Capture aligned datasets in a single session, so you can correlate structure and function without added complexity.

By integrating molecular imaging with high-performance anatomical CT and optical workflows, researchers can localize biological signals precisely and compare datasets directly. This reduces uncertainty, improves interpretability, and strengthens confidence in experimental outcomes.

Discover Multimodality

Support for tracer development and theranostic research

Evaluate established and next-generation theranostic agents directly, so you can translate faster with fewer assumptions.
MILabs is the go-to imaging partner for theranostic research, with the broadest proven capability across therapeutic isotopes and energy ranges. With ultra-high sensitivity and validated performance across a wide spectrum of gamma energies, researchers can image challenging agents without relying on surrogate tracers, compare control and targeted compounds in the same model, and quantify biodistribution and biological response with stronger statistical power and fewer animals.

Hear from the experts

Simultaneous imaging of PET, SPECT and CT in oncology

Name and title - Dr Kersemens, a lead biological scientist at the University of Oxford

“By using simultaneous imaging of PET, SPECT and CT, we can have control probe and targeted imaging probe done in the same animal. The advantage for us is that we can see how the control probe behaves in relation to a specific probe in the same tumor at the same time. The resulting statistics are much better, and we use significantly fewer animals than before.”
Discover more

Simultaneous molecular imaging in preclinical oncology at the University of Oxford

Name and title - Bart Cornelissen, PhD, Associate Professor, University of Oxford

Researchers at the University of Oxford use MILabs imaging systems to compare control and targeted tracers within the same tumor, enabling more robust statistics while reducing animal usage. This approach supports studies across oncological biology, tracer development, and therapeutic evaluation.
Discover more

Want to know what MILabs can do for you?

Request more information